Skip to content

Dendritic-Cell (DC) Targeting Universal Vaccine for Influenza Infection

A novel DC-targeting vaccine platform using Ebola glycoprotein (EboGP) DC-targeting domain-based fusion protein technology

Published: 1st June 2022
Dendritic-Cell (DC) Targeting Universal Vaccine for Influenza Infection
Kateryna_Kon, https://stock.adobe.com/uk/176296738, stock.adobe.com
Patents
  • PCT/CA2020/0151409
IP Status
  • Patented
Seeking
  • Development partner
  • Commercial partner
  • Licensing